medigraphic.com

2018, Número 2

<< Anterior Siguiente >>

Enf Infec Microbiol 2018; 38 (2)


Biología molecular del virus de la hepatitis c

Dueñas CS, Acosta RN, Morales GJ, García FWO

Idioma: Español
Referencias bibliográficas: 47
Paginas: 51-55
Archivo PDF: 195.88 Kb.


RESUMEN

El virus de la hepatitis c (VHC) es un virus de ARN de cadena simple, de polaridad positiva, que se clasifica dentro del género Hepacivirus de la familia Flaviviridae. Los aislamientos del VHC pueden separarse en, al menos, seis tipos principales, subdivididos en más de 50 subtipos. En esta revisión se describen las características del genoma y de las proteínas, la heterogeneidad y el ciclo del VHC.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mayo, M.A. y Pringle, C.R., “Virus taxonomy 1997”, J Gen Virol, 1998, 79: 649-657.

  2. Feinstone, S.M., Mihalik, K.B., Kimimura, T., Alter, H.J., London, W.T. y Purcell, R.H., “Inactivation of hepatitis c virus and non-a, non-b hepatitis by chloroform”, Infect Immunol, 1993, 41: 816-821.

  3. Takahashi, K., Kishimoto, S., Yoshizawa, H., Okamoto, H., Yoshikawa, A. y Mishiro, S., “p26 protein and 33 nm particle associated with nucleocapsid of hepatitis c virus recovered from the circulation of infected hosts”, Virology, 1992, 191: 431-434.

  4. Prince, A.M., Huima-Byron, T., Parker, T.S. y Levine, D.M., “Visualization of Hepatitis c virions and putative defective interfering particles isolated from low-density lipoproteins”, J Virol Hepatitis, 1996, 3: 11-17.

  5. Shimizu, Y.K., Feinstones, S.M., Kohara, M., Purcell, R.H. y Yoshikura, H., “Hepatitis c virus: detection of intracellular virus particles by electron microscopy”, Hepatology, 1996, 23: 205-209.

  6. Bukh, J., Purcell, R.H. y Miller, R.H., “Sequence analysis of the 5’ noncoding region of hepatitis c virus”, Proc Natl Acad Sci USA, 1992, 89 (11): 4942-4946.

  7. Honda, M., Ping, L.-H., Rijnbrand, R.C.A., Amphlett, E., Clarke, B., Rowlands, D.T. y Lemon, S.M., “Structural requirements for initiation of translation by internal ribosome entry within genome-lengh hepatitis c virus rna”, Virology, 1996, 22: 31-42.

  8. Manabe, S., Fuke, I., Tanishita, O., Kaji, C., Gomi, Y., Yoshida, S., Mori, C., Takamizawa, A., Yosida, I. y Okayama, H., “Production of nonstructural proteins of hepatitis c virus requires a putative viral protease encoded by ns3”, Virology, 1994, 198 (2): 636-644.

  9. Takamizawa, A., Mori, C., Fuke, I., Manabe, S., Murakami, S., Fujita, J., Onishi, E., Ando, K.Y., Yoshida, I. y Okayama, H., “Structure and organization of the hepatitis c virus genome isolate from human carriers”, J Virol, 1991, 65: 1105-1113.

  10. Bukh, J., Miller, R.H. y Purcell, R.H., “Genetic heterogeneity of hepatitis c virus: quasispecies and genotypes”, Semin Liver Dis, 1995, 15 (1): 41-63.

  11. Santolini, E., Migliaccio, G. y La Monica, N., “Biosynthesis and biochemical properties of the hepatitis c virus core protein”, J Virol, 1994, 68: 3631-3641.

  12. Lo, S.-Y., Masiarz, F., Hwang, S.B., Lai, M.M.C. y Ou, J.-H., “Differential subcellular localization of hepatitis c virus core gene products”, Virology, 1995, 213: 455-461.

  13. Acosta-Rivero, N., Álvarez-Obregón, J.C., Musacchio, A., Falcon, V., Dueñas-Carrera, S., Marante, J., Menéndez, I. y Morales, J., “In vitro self-assembled hcv core virus-like particles induce a strong antibody immune response in sheep”, Biochem Biophys Res Commun, 2002, 290 (1): 300-304.

  14. Acosta-Rivero, N., Rodríguez, A., Musacchio, A., Falcón, V., Suárez, V.M., Martínez, G., Guerra, I., Paz-Lago, D., Morera, Y., De la Rosa, M.C., Morales-Grillo, J. y Dueñas-Carrera, S., “In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived hcv core protein”, Biochem Biophys Res Commun, 2004, 325 (1): 68-74.

  15. Acosta-Rivero, N., Rodríguez, A., Mussachio, A., Poutu, J., Falcón, V., Torres, D., Aguilar, J.C., Linares, M., Alonso, M., Pérez, A., Menéndez, I., Morales-Grillo, J., Márquez, G. y Dueñas-Carrera, S., “A c-terminal truncated hepatitis c virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids”, Biochem Biophys Res Commun, 2005, 334 (3): 901-906.

  16. Chang, S.C., Yen, J.-H., Kang, H.-Y., Jang, M.-H. y Chang, M.-F., “Nuclear localization signals in the core protein of hepatitis c virus”, Biochem Biophys Res Commun, 1994, 205 (2): 1284-1290.

  17. Hwang, S.B., Lo, S.-Y., Ou, J.-H. y Lai, M.M.C., “Detection of cellular proteins and viral core protein interacting with the 5’ untranslated region of hepatitis c virus rna, J Biomed Sci, 1995, 2: 227-236.

  18. Reed, K.E. y Rince, M.C., “Molecular characterization of hepatitis c virus in hepatitis c virus”, en H.W. Reesink (ed.), Curr Stud Hematol Blood Transf, Basilea, Karger, 1998, 2: 1-37.

  19. Acosta-Rivero, N., Rodríguez, A., Musacchio, A., Falcón, V., Suárez, V.M., Chávez, L., Morales-Grillo, J., Dueñas-Carrera, S., “Nucleic acid binding properties and intermediates of hcv core protein multimerization in Pichia pastoris”, Biochem Biophys Res Commun, 2004, 323 (3): 926-931.

  20. Matsumoto, M., Hwang, S.B., Jeng, K.-S., Zhu, N. y Lai, M.M.C., “Homotypic interaction and multimerization of hepatitis c core protein”, Virology, 1996, 218: 43-51.

  21. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T. y Koike, K., “The core protein of hepatitis c virus induces hepatocellular carcinoma in transgenic mice”, Nat Med, 1998; 4: 1065-1067.

  22. Marusawa, H., Hijikata, M., Chiba, T. y Shimotohno, K., “Hepatitis c virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via nf-kappa b activation”, J Virol, 1999, 73: 4713-4720.

  23. Kittlesen, D.J., Chianese-Bullock, K.A., Yao, Z.Q., Braciale, T.J. y Hahn, Y.S., “Interaction between complement receptor gc1qr and hepatitis c virus core protein inhibits t-lymphocyte proliferation”, J Clin Invest, 2000, 106: 1239-1249.

  24. Fournillier, A., Cahour, A., Escriou, N., Girard, M. y Wychowski, C., “Processing of the e1 glycoprotein of hepatitis c virus expressed in mammalian cells”, J Gen Virol, 1996, 77: 1055-1064.

  25. Kato, N., “Molecular virology of hepatitis c virus”, Acta Med Okayama, 2001, 55 (3): 133-159.

  26. Griffin, S., Clarke, D., McCormick, C., Rowlands, D. y Harris, M., “Signal peptide cleavage and internal targeting signals direct the hepatitis c virus p7 protein to distinct intracellular membranes”, J Virol, 2005, 79 (24): 15525- 15536.

  27. Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dona, C., Weiner, A.J., Lau, J.Y., Choo, Q.-L., Chien, D., Pileri, P., Houghton, M. y Abrignani, S. “A quantitative test to estimate neutralizing antibodies to the hepatitis c virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells”, Proc Natl Acad Sci USA, 1996, 93: 1759-1763.

  28. Gorbalenya, A.E. y Snijder, E.J., “Viral cysteine proteinases”, Persp Drug Discov Des, 1996, 6: 64-86.

  29. Steinkühleer, C., Tomei, L., De Francesco, R., “In vitro activity of hepatitis c virus ns3 purified from recombinant baculovirus-infected sf9 cells”, J Biol Chem, 1996, 271: 6367- 6373.

  30. Kiiver, K., Merits, A., Ustav, M. y Zusinaite, E., “Complex formation between hepatitis c virus ns2 and ns3 proteins”, Virus Res, 2006, 117 (2): 264-272.

  31. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Izumi, N., Marumo, F. y Sato, C., “Comparison of full-length sequences of interferon-sensitive and resistant hepatitis 1b”, J Clin Invest, 1995; 96: 224-230.

  32. Kato, N. “Genome of human hepatitis c virus (hcv): gene organization, sequence diversity, and variation”, Microb Comp Genomics, 2000, 5 (3): 129-151.

  33. Hwang, S.B., Park, K.-J., Kim, Y.-S., Syng, Y.C., Lai, M.M.C., “Hepatitis c virus ns5b protein is a membrane associated phosphoprotein with a predominantly perinuclear localization”, Virology, 1997, 227: 439-446.

  34. Hamamoto, I., Nishimura, Y., Okamoto, T., Aizaki, H., Liu, M., Mori, Y., Abe, T., Suzuki, T., Lai, M.M., Miyamura, T., Moriishi, K. y Matsuura, Y., “Human vap-b is involved in hepatitis c virus replication through interaction with ns5a and ns5b”, J Virol, 2005; 79 (21): 13473-13482.

  35. Naka, K., Dansako, H., Kobayashi, N., Ikeda, M. y Kato, N., “Hepatitis c virus ns5b delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes”, Virology, 2006; 346 (2): 348-362.

  36. Bartenschlager, R. y Lohmann, V., “Replication of the hepatitis c virus”, Baillieres Best Pract Res Clin Gastroenterol, 2000, 14 (2): 241-254.

  37. Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspe, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D.G., Okamoto, H., Pawlotsky, J.M., Penin, F., Sablon, E., Shin-I, T., Stuyver, L.J., Thiel, H.J., Viazov, S., Weiner, A.J. y Widell, A., “Consensus proposals for a unified system of nomenclature of hepatitis c virus genotypes”, Hepatology, 2005, 42 (4): 962-973.

  38. Zeuzem, S., “The kinetics of hepatitis c virus infection”, Clin Liver Dis, 2001, 5 (4): 917-930.

  39. Abe, K., Inchauspe, G. y Fijisawa, K., “Genomic characterization and mutation rate of hepatitis c virus in patients who contracted hepatitis during an epidemic of nanbh in Japan”, J Gen Virol, 1992, 73: 2725-2729.

  40. Alfonso, V., Mbayed, V.A., Sookoian, S. y Campos, R.H., “Intra-host evolutionary dynamics of hepatitis c virus e2 in treated patients”, J Gen Virol, 2005, 86: 2781-2786.

  41. Lamelin, J.P., Zoulim, F. y Trépo, C., “Lymphotropism of hepatitis b and c viruses: an update and a newcomer”, Int J Clin Lab Res, 1995, 25: 1-6.

  42. Zignego, A.L., De Carli, M., Monti, M., Careccia, G., La Villa, G., Giannini, C., D’Elios, M.M., Del Prete, G. y Geentilini, P., “Hepatitis c virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients”, J Med Virol, 1995, 47: 58-64.

  43. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Hougton, M., Rosa, D., Grandi, G. y Abrignani, S., “Binding of hepatitis c virus to cd81”, Science, 1998, 282: 938-941.

  44. Agnello, V., Abel, G., Elfahal, M., Knight, G.B, y Zhang, Q.X., “Hepatitis c virus and other flaviviridae viruses enter cells via low density lipoprotein receptor”, Proc Natl Acad Sci USA, 1999, 96 (22): 12766-12771.

  45. Lindenbach, B.D. y Rice, C.M., “Unravelling hepatitis c virus replication from genome to function”, Nature, 2005, 436: 933-938.

  46. Blanchard, E., Brand, D., Trassard, S., Goudeau, A. y Roingeard, P., “Hepatitis c virus-like particle morphogenesis”, J Virol, 2002, 76 (8): 4073-4079.

  47. McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., Goodman, Z.D., Ling, M.H., Cort, S. y Albrecht, J.K., “Interferon alfa 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis c”, N Engl J Med, 1998, 339: 1485-1492.




2020     |     www.medigraphic.com